HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jan M Langrehr Selected Research

Jan M Langrehr Research Topics

Disease

8Infections
10/2007 - 04/2002
6Fibrosis (Cirrhosis)
08/2012 - 04/2002
5Hepatitis C
07/2007 - 01/2004
5Neoplasms (Cancer)
07/2007 - 09/2005
3Pancreatic Neoplasms (Pancreatic Cancer)
05/2007 - 11/2006
2Inflammation (Inflammations)
07/2007 - 02/2005
2Bacterial Infections (Bacterial Infection)
07/2007 - 01/2005
2Disease Progression
12/2006 - 02/2005
2Hypoxia (Hypoxemia)
11/2004 - 02/2004
2Ischemia
11/2004 - 02/2004
2Reperfusion Injury
10/2004 - 02/2004
1Hepatocellular Carcinoma (Hepatoma)
08/2012
1Hernia (Hernias)
10/2007
1Hydrothorax
10/2007
1Chronic Kidney Failure (Chronic Renal Failure)
10/2007
1Hepatitis
07/2007
1Pheochromocytoma
07/2007
1Inguinal Hernia (Direct Inguinal Hernia)
06/2007
1Subcutaneous Emphysema
06/2007
1Margins of Excision
06/2007
1Neoplasm Metastasis (Metastasis)
04/2007
1Liver Neoplasms (Liver Cancer)
04/2007
1Convalescence
01/2007
1Body Weight (Weight, Body)
01/2007
1Pancreatic Ductal Carcinoma
11/2006
1Carcinogenesis
11/2006
1Adenocarcinoma
11/2006
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
03/2006
1Diabetes Mellitus
03/2006
1Thrombosis (Thrombus)
10/2005
1Bile Duct Neoplasms (Bile Duct Cancer)
09/2005
1Cholangiocarcinoma
09/2005
1Acute Liver Failure (Fulminant Hepatic Failure)
08/2005
1Cholestasis
06/2005
1Shock
11/2004
1Wounds and Injuries (Trauma)
06/2004
1Chronic Hepatitis C
01/2004
1Viremia
01/2004
1Sclerosing Cholangitis
01/2003
1Autoimmune Diseases (Autoimmune Disease)
01/2003
1Pneumonia (Pneumonitis)
05/2002
1Reinfection
04/2002
1Hepatitis B
04/2002

Drug/Important Bio-Agent (IBA)

5SteroidsIBA
01/2007 - 10/2004
2Anti-Bacterial Agents (Antibiotics)IBA
07/2007 - 01/2005
2GemcitabineFDA Link
05/2007 - 12/2006
2Antiviral Agents (Antivirals)IBA
02/2007 - 02/2005
2MethylprednisoloneFDA LinkGeneric
01/2007 - 02/2004
2Muromonab-CD3 (Muromonab CD3)FDA Link
08/2005 - 05/2002
2Proteins (Proteins, Gene)FDA Link
06/2005 - 11/2004
2Messenger RNA (mRNA)IBA
11/2004 - 08/2004
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2004 - 01/2003
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
06/2007
13-aminobenzamideIBA
05/2007
1Poly(ADP-ribose) Polymerase InhibitorsIBA
05/2007
1InterferonsIBA
02/2007
1Ribavirin (Virazole)FDA LinkGeneric
02/2007
1Sodium ChlorideFDA LinkGeneric
01/2007
1Biomarkers (Surrogate Marker)IBA
12/2006
1CilengitideIBA
12/2006
1Angiogenesis InhibitorsIBA
12/2006
1LigandsIBA
11/2006
1Transcription Factors (Transcription Factor)IBA
11/2006
1PPAR gammaIBA
11/2006
1Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2006
1Glucose (Dextrose)FDA LinkGeneric
03/2006
1CholesterolIBA
03/2006
1Tacrolimus (Prograf)FDA LinkGeneric
03/2006
1CreatinineIBA
03/2006
1Ganciclovir (Cytovene)FDA LinkGeneric
08/2005
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
02/2005
1Calcineurin InhibitorsIBA
02/2005
1CalcineurinIBA
02/2005
1BilirubinIBA
11/2004
1Heme Oxygenase-1IBA
11/2004
1EnzymesIBA
11/2004
1HLA-DR Antigens (HLA-DR)IBA
01/2003
1HLA-A Antigens (HLA-A)IBA
04/2002
1Immunoglobulins (Immunoglobulin)IBA
04/2002

Therapy/Procedure

13Liver Transplantation
08/2012 - 03/2002
5Transplantation
07/2007 - 11/2004
5Therapeutics
07/2007 - 01/2005
3Length of Stay
07/2007 - 01/2005
2Enteral Nutrition (Feeding, Tube)
07/2007 - 01/2005
1Catheters
10/2007
1Peritoneal Dialysis
10/2007
1Kidney Transplantation
10/2007
1Critical Care (Surgical Intensive Care)
07/2007
1Laparotomy
07/2007
1Pancreaticoduodenectomy
07/2007
1Operative Surgical Procedures
06/2007
1Vascular Access Devices (Arterial Line)
04/2007
1Drug Therapy (Chemotherapy)
04/2007
1Withholding Treatment
02/2007
1Aftercare (After-Treatment)
02/2007
1Artificial Respiration (Mechanical Ventilation)
08/2005
1Resuscitation
11/2004
1Laparoscopic Cholecystectomy
06/2004
1Renal Dialysis (Hemodialysis)
08/2003
1Splenectomy
05/2002